Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2006 4
2007 4
2008 4
2009 4
2010 3
2011 1
2012 5
2013 2
2014 1
2016 2
2018 2
2019 5
2020 6
2021 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
Toi Y, Sugawara S, Sugisaka J, Ono H, Kawashima Y, Aiba T, Kawana S, Saito R, Aso M, Tsurumi K, Suzuki K, Shimizu H, Domeki Y, Terayama K, Nakamura A, Yamanda S, Kimura Y, Honda Y. Toi Y, et al. Among authors: yamanda s. JAMA Oncol. 2019 Mar 1;5(3):376-383. doi: 10.1001/jamaoncol.2018.5860. JAMA Oncol. 2019. PMID: 30589930 Free PMC article.
Inflammatory biomarkers in asthma-COPD overlap syndrome.
Kobayashi S, Hanagama M, Yamanda S, Ishida M, Yanai M. Kobayashi S, et al. Among authors: yamanda s. Int J Chron Obstruct Pulmon Dis. 2016 Sep 7;11:2117-2123. doi: 10.2147/COPD.S113647. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27660429 Free PMC article.
Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers.
Aiba T, Hattori C, Sugisaka J, Shimizu H, Ono H, Domeki Y, Saito R, Kawana S, Kawashima Y, Terayama K, Toi Y, Nakamura A, Yamanda S, Kimura Y, Suzuki Y, Niida A, Sugawara S. Aiba T, et al. Among authors: yamanda s. PLoS One. 2021 Nov 29;16(11):e0260500. doi: 10.1371/journal.pone.0260500. eCollection 2021. PLoS One. 2021. PMID: 34843570 Free PMC article.
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy.
Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, Miyauchi E, Kojima T, Fujita Y, Hino T, Yamanda S, Suzuki T, Fukuizumi A, Sakakibara T, Harada T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group. Okuma Y, et al. Among authors: yamanda s. Lung Cancer. 2020 Oct;148:122-128. doi: 10.1016/j.lungcan.2020.08.014. Epub 2020 Aug 20. Lung Cancer. 2020. PMID: 32890794
Adiponectin pathway attenuates malignant mesothelioma cell growth.
Niu K, Asada M, Okazaki T, Yamanda S, Ebihara T, Guo H, Zhang D, Nagatomi R, Arai H, Kohzuki M, Ebihara S. Niu K, et al. Among authors: yamanda s. Am J Respir Cell Mol Biol. 2012 Apr;46(4):515-23. doi: 10.1165/rcmb.2011-0068OC. Epub 2011 Nov 17. Am J Respir Cell Mol Biol. 2012. PMID: 22095628
Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer.
Ono K, Ono H, Toi Y, Sugisaka J, Aso M, Saito R, Kawana S, Aiba T, Odaka T, Matsuda S, Saito S, Narumi A, Ogasawara T, Shimizu H, Domeki Y, Terayama K, Kawashima Y, Nakamura A, Yamanda S, Kimura Y, Honda Y, Sugawara S. Ono K, et al. Among authors: yamanda s. Cancer Med. 2021 Jul;10(14):4796-4804. doi: 10.1002/cam4.4045. Epub 2021 Jun 13. Cancer Med. 2021. PMID: 34121358 Free PMC article.
40 results